Real-World Evidence

Care Pathways Optimization

Providing a full spectrum of real-world evidence services

As part of Alira Health, the Care Factory team supports clients in all aspects of care pathways optimization, including:
  • Design of data models and study methodologies, including data set definition and analytics methodologies
  • Management of the SNDS process, including protocol of research, and procedure follow-up for the CESREES and CNIL
  • Data management and implementation of methodologies
  • Design of new remuneration models, including type of model (e.g., risk sharing performance), trackers, indicators, and methodologies
  • Impacts modeling and comparisons with existing solutions
  • Managing experts throughout the process

Data collection and sourcing

We collect the following data

  • Patient profiles, including age, gender, and welfare
  • Disease information, including diagnostic and co-morbidities
  • Drug prescriptions
  • Claims

Through these sources

  • Literature
  • Practitioners or coding expert interviews
  • SNIIRAM (event and total costs of care), EGB
  • PMSI (event during hospital stays)
  • CEPIDC (deceased cause)
  • Open data (open DAMIR)

Why partner with Alira Health and Care Factory?

Together, Alira Health and Care Factory provide services across the ecosystem for members of the healthcare industry looking to value the efficacy of care.

As innovative, market leaders in real-world evidence and data collection, we work closely with clients looking to experiment with new remuneration models, including performance, episodes, and yearly fees.

Alira Health Lifestyle 2

Related News

Due Diligence MedTech Patient Engagement Pharma
Multimedia April 12, 2021
Evolution of the Drug Delivery Systems Industry and its Increasing Role in Driving Patient Outcomes
In the third episode, Amira Ghozali, Aptar Pharma, Kenny Carberry, and Aude Ouensanga, discuss the evolution of the DDS industry, its relationship with Pharma, and its increasing role(...)
News April 12, 2021
Alira Health Strengthens its Growth Strategy with a $35M Funding, led by Creadev
Alira Health strengthens its growth strategy with a $35M funding, led by Creadev.
Clinical
Publications April 6, 2021
Unlocking the Database Lock Process
In our latest whitepaper, in collaboration with CROS NT, Alira Health’s Vice President Clinical Development, Christopher Rao and Amanda Cross, US Country Manager Executive Director,(...)
Due Diligence MedTech Patient Engagement
Publications March 24, 2021
Drug Delivery Devices (DDD): Increasing Role in Patient Outcome and Future Trends, New England’s Global Appeal to Foster Collaboration
Download our newest report, Drug Delivery Devices (DDD): Increasing role in patient outcome and future trends, New England’s global appeal to foster collaboration. In this report,(...)
Research & Development
News March 15, 2021
Alira Health Welcomes Nikole Siegmund, Vice President, Preclinical
BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, is pleased to announce that Nikole Siegmund has joined the firm(...)
Research & Development
News March 9, 2021
A Primer on Potency Assays for Release of Biologics
A key criterion in determining the quality of a biologic product is whether it has maintained its biological activity or “potency.”
MedTech
News March 3, 2021
The 2021 MedTech Contract Manufacturing Report
Download our latest piece: The 2021 MedTech Contract Manufacturing Report. Learn how despite the ongoing pandemic, the Medical Device and CDMO industries are positioned to perform(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.